Right now the price per share is 1,67$, Ocuphire Pharma Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Bernhard Hoffmann (Vice President-Corporate Development & Operations), Mina Patel Sooch (President, Chief Executive Officer & Director), Mitchell Brigell (Head-Clinical Development & Strategy), Amy Rabourn (VP of Finance) and its address is 37000 GRAND RIVER AVENUE SUITE 120, FARMINGTON HILLS, Michigan, 48335, United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 1,67$ moving between 1,65$ and 1,68$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last value we have registered for the opening is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
